Reported inhibitor incidence in FVIII PUP studies: comparing apples with oranges?

This publication has 6 references indexed in Scilit:

• The epidemiology of inhibitors in haemophilia A: a systematic review
  Haemophilia, 2003
• Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII
  Haemophilia, 2001
• Incidence of inhibitors in haemophilia A patients – a review of recent studies of recombinant and plasma‐derived factor VIII concentrates
  Haemophilia, 1999
• Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates
  Thrombosis and Haemostasis, 1999
• Detection by PCR and Hphl Restriction Analysis of a Splice Site Mutation at the 5’ End of Intron 15 of the Platelet GPIIb (αIIb Integrin) Gene Responsible for Glanzmann’s Thrombasthenia Type I in Gypsies Originating from the Strasbourg Area
  Thrombosis and Haemostasis, 1995
• A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group
  Blood, 1993